Assiut University: Pre-Eclampsia trials
The registry lists 32 Pre-Eclampsia studies with Assiut University as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 4Phase 3 3Phase 4 6No phase 21(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Prevalence of Asymptomatic Bacteriuria Among Pregnant Women With Pre-eclampsia in Women Health Hospital Assiut UniversityNot yet recruitingNCT07866196
- Dexamethasone Versus Ondansetron for Preventing Post-Spinal Hypotension in PreeclampsiaNot yet recruitingNCT07793760Phase 4
- Dexmedetomidine Nebulization for Attenuation of Pressor Response to Laryngoscopy and Endotracheal Intubation in Sever Preeclamptic PatientsNot yet recruitingNCT07164326Not applicable
- Role of Vaspin in Pathophysiology of Pre-eclampsiaNot yet recruitingNCT06437535
- Intravenous Labetalol vs Phentolamine for the Management of Severe Preeclampsia.Not yet recruitingNCT06385600Not applicable
- co Ihibtory Receptor in PreeclampsiaNot yet recruitingNCT05294952Phase 4
- Pulmonary Artery Doppler in Preeclamptic MothersCompletedNCT06755073
- Fetal Renal Artery Doppler in Patients With PreeclampsiaCompletedNCT06395974
- Knowledge and Attitude of Pregnant Women Towards Preeclampsia in Assiut GovernorateCompletedNCT05955690
- Comparison Between the Use of Phentolamine Versus Glyceryl Trinitrate for Their Effect on Renal Function in Pre-eclampsia Patients in ICUCompletedNCT05687669Phase 4
- State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis AssaysStatus unknownNCT05625763
- Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic WomenStatus unknownNCT05622838
- Body Fat Index for Obstetric Risk StratificationStatus unknownNCT05533996Not applicable
- Improved Characterisation of EclampsiaStatus unknownNCT05199558
- Dexamedtomidine in Control of Intracranial Pressure in PreeclampsiaStatus unknownNCT05119101Phase 1
- Predictors of Pulmonary Edema in Severe PreeclampsiaStatus unknownNCT05095974
- Uterotonics for Severe PreeclampsiaCompletedNCT04756661Not applicable
- Hydroxychloroquine in Prevention of PreeclampsiaCompletedNCT04755322Not applicable
- Cardiovascular Changes in Infants of Preeclampsia MotherStatus unknownNCT04699825Not applicable
- Lignocaine Nebulization for Attenuation of Intubation Stress ResponseStatus unknownNCT04441073Phase 4
- Effect of Rosuvastatin on the Clinical Features of PreeclampsiaStatus unknownNCT04303806Phase 2
- Role and Expression of MXRA5 in Placental Connective Tissue Remodelling in PreeclampsiaStatus unknownNCT04287998
- Progesterone in Expectantly Managed Early-onset PreeclampsiaCompletedNCT04077853Phase 4
- Impact of Body Mass Index on Serum Maternal and Fetal Magnesium LevelStatus unknownNCT03928691
- Peri-operative Dexmedetomidine Infusion in Pre-eclamptic PatientsCompletedNCT03391609Phase 2/3
- Predictors of Intrauterine Growth RestrictionStatus unknownNCT03349671
- Use of Sildenafil Citrate in Management of Mild Pre-eclampsiaStatus unknownNCT03262961Phase 2/3
- miRNA-452 in Patients With Preeclampsia and Its Correlation With MMP-9CompletedNCT03258125
- Esomeprazole in Treatment of Early Onset Preeclampsia (ESOPE Trial)CompletedNCT03213639Phase 2/3
- Diagnostic Value of MicroRNA 210 In PreeclampsiaStatus unknownNCT03193554
- Efficacy and Safety of 1 g Vs 2 g Per Hour Intravenous Maintenance Dose of MgSO4 in Women With Severe Pre-eclampsiaCompletedNCT03164304Phase 4
- Pre-eclampsia and Biochemical MarkersCompletedNCT02665897